Current and emerging commercial optical biosensors.
The field of commercial optical biosensors is rapidly evolving, with new systems and detection methods being developed each year. This review outlines the currently available biosensor hardware and highlights unique features of each platform. Affinity-based biosensor technology, with its high sensitivity, wide versatility and high throughput, is playing a significant role in basic research, pharmaceutical development, and the food and environmental sciences. Likewise, the increasing popularity of biosensors is prompting manufacturers to develop new instrumentation for dedicated applications. We provide a preview of some of the emerging commercial systems that are dedicated to drug discovery, proteomics, clinical diagnostics and routine biomolecular interaction analysis.
Baird
C L
CL
Center for Biomolecular Interaction Analysis, University of Utah, Salt Lake City, UT 84132, USA.
Myszka
D G
DG
D015374:Biosensing Techniques / Q000295:instrumentation* / Q000379:methods* / Q000639:trends*; D004345:Drug Industry / Q000295:instrumentation / Q000639:trends; D011506:Proteins / Q000737:chemistry; D020349:Surface Plasmon Resonance / Q000295:instrumentation / Q000379:methods; D013997:Time Factors
D011506:Proteins